Holger Wesche, Chief Scientific Officer at Harpoon Therapeutics, Inc. (HARP), sold 1,400 shares at $14.09 ($20K) on 2020-05-12, disclosed to the SEC on 2020-05-13.
Scheduled sale ($20k) by Chief Scientific Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| HARP | SELL | 2021-01-06 | $314K | — | Filing → |
| HARP | SELL | 2020-10-05 | $163K | — | Filing → |
| HARP | SELL | 2020-07-02 | $162K | — | Filing → |